Overview
PDS Biotech’s oncology pipeline leverages the Versamune® platform and Versamune® plus PDS01ADC in combination with proprietary tumor-specific proteins or peptides (antigens) in the development of targeted cancer immunotherapies. PDS Biotech’s infectious disease pipeline combines the Infectimune® platform technology with pathogen-specific antigens in the development of preventive infectious disease vaccines.
